Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Nicole Fawcett photo
Health Lab
How Targeting Metabolism Can Defeat Cancer Stem Cells
New research explains why stem cells become resistant to cancer treatment and opens a clever new way to go after them.
Health Lab
Surgeons Influence Receipt of Genetic Testing After Breast Cancer Diagnosis
Surveys of patients and their surgeons showed genetic testing rates ranged from 26 to 72 percent, depending on the surgeon.
Health Lab
Researchers Pinpoint New Subtype of Prostate Cancer
Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.
Health Lab
Two Simple Steps to Prevent Cervical Cancer
Learn how HPV, the virus that causes cervical cancer, is transmitted and two things you can do to prevent cervical cancer and other HPV associated cancers.
Health Lab
Genome’s Dark Matter Sheds Light on Prostate Cancer Challenge
Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.
Health Lab
A Cascade of Immune Processes Offers Insights to Triple-Negative Breast Cancer
Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.
Medicine at Michigan
Challenges and Opportunities
Philanthropy, internal funding can fill gaps when federal funding decreases
Medicine at Michigan
Rogel Cancer Center
Shaping the future of cancer care and research
Health Lab
How Signals Get Inside Cancer Cells and Spur Aggressive Growth
A surprising finding explains how a crucial cancer gene impacts cell signaling to drive cancer growth.
Health Lab
Tight Federal Funding a Challenge and Opportunity for Cancer Research
A newly announced $150 million gift to the University of Michigan Rogel Cancer Center will help fill the gaps in federal funding and support high-risk, high-reward research.
News Release
With $150M gift, Rogels will help U-M Cancer Center transform cancer research, care
Richard and Susan Rogel are on a mission to boost innovative cancer research and develop the next generation of cancer pioneers -- and they are committing $150 million to the University of Michigan Comprehensive Cancer Center to realize that vision.
Health Lab
Some Breast Cancer Patients Missing Out on Genetic Counseling
A new study finds only half of women who could benefit from genetic testing get it, and often not before they have surgery.
Health Lab
Why Basal Cell Tumors Return When Drug Treatment Stops
Researchers uncover a mechanism that explains why a Hedgehog inhibitor kills skin cancer, but not completely.
Health Lab
Interactive Tool Can Help Educate Cancer Patients on Their Options
Breast cancer patients who used an interactive website were more informed about options and felt better prepared to make a treatment choice.
Health Lab
Who Might Benefit from Immunotherapy? Study Suggests Possible Marker
PD-L1 in cells within the tumor microenvironment and lymph nodes may matter more than PD-L1 in tumors, researchers report in a new study.
  • …
  • 7
  • 8
  • 9
    •